The incidence and predictors of thromboembolic events in patients with lung cancer
- PMID: 24574864
- PMCID: PMC3918375
- DOI: 10.1155/2014/125706
The incidence and predictors of thromboembolic events in patients with lung cancer
Abstract
Patients with lung cancer experience elevated risk of venous thromboembolism. Cancer patients with thrombosis have a shorter life expectancy and the occurrence of VTE worsens the quality of life and may delay, interrupt, or completely halt the cancer therapy. In a large cohort of lung cancer patients we monitored the incidence of venous thromboembolism and we identified groups of patients with the highest risk of venous thromboembolism suitable for antithrombotic prophylaxis, which could favourably affect their morbidity and mortality.
Figures
References
-
- Trousseau A. Phlegmasia Alba Dolens. London, UK: Clinique Medicale de l’Hotel Dieu de Paris; 1865.
-
- Leclerc J. Venous Thromboembolic Disorders. Philadelphia, Pa, USA: Lea & Febiger; 1991.
-
- Nordstrom M, Lindblad B, Bergqvist D, Kjellstrom T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. Journal of Internal Medicine. 1992;232(2):155–160. - PubMed
-
- Falanga A. The incidence and risk of venous thromboembolism associated with cancer and nonsurgical cancer treatment. Cancer Investigation. 2009;27(1):105–115. - PubMed
-
- Stein PD, Beemath A, Meyers FA, Skaf E, Sanchez J, Olson RE. Incidence of venous thromboembolism in patients hospitalized with cancer. American Journal of Medicine. 2006;119(1):60–68. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
